We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

31 hedge funds and large institutions have $304K invested in LakeShore Biopharma Warrants in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 31 → 31 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

90% less capital invested

Capital invested by funds: $3.07M → $304K (-$2.76M)

Holders
31
Holders Change
–
Holders Change %
0%
% of All Funds
0.49%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
2
Increased
1
Reduced
2
Closed
2
Calls
$56K
Puts
–
Net Calls
+$56K
Net Calls Change
-$129K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$17K
2
UBS Group
UBS Group
Switzerland
+$382
3
CS
Clear Street
New York
+$9

Top Sellers

Rank Fund Capital Flow
1
SCM
Segantii Capital Management
Hong Kong
-$320K
2
PC
Periscope Capital
Ontario, Canada
-$15.6K
3
AA
AQR Arbitrage
Connecticut
-$2.47K
4
ETH
Exos TFP Holdings
New York
-$85
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$49.5K – – –
VAM
2
Valliance Asset Management
Hong Kong
$35.3K – – –
BP
3
BFAM Partners
Hong Kong
$25.9K – – –
HCM
4
Highbridge Capital Management
New York
$25.3K – – –
SLM
5
Snow Lake Management
California
$23.5K – – –
Jane Street
6
Jane Street
New York
$23.4K – – –
FC
7
Finepoint Capital
Massachusetts
$23K – – –
ICM
8
Ionic Capital Management
New York
$12.8K – – –
BCL
9
Bracebridge Capital LLC
Massachusetts
$10.9K – – –
CAC
10
Cowen and Company
New York
$9.4K +$17K +199,999 New
Calamos Advisors
11
Calamos Advisors
Illinois
$6.86K – – –
QGA
12
Q Global Advisors
Texas
$6K – – –
WA
13
Whitebox Advisors
Minnesota
$5.88K – – –
RCM
14
Radcliffe Capital Management
Pennsylvania
$5.44K – – –
SCM
15
Saba Capital Management
New York
$5.3K – – –
SCM
16
Shaolin Capital Management
Florida
$5K – – –
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$4.7K – – –
Walleye Capital
18
Walleye Capital
New York
$4.7K – – –
ETH
19
Exos TFP Holdings
New York
$4.65K -$85 -1,000 -1%
CF
20
Cantor Fitzgerald
New York
$3.62K – – –
AA
21
AQR Arbitrage
Connecticut
$2.71K -$2.47K -29,018 -33%
CS
22
Clear Street
New York
$2.22K +$9 +100 +0.2%
SVI
23
Strategic Vision Investment
Hong Kong
$1.83K – – –
EC
24
Elequin Capital
New York
$1.76K – – –
MC
25
Meteora Capital
Florida
$1.18K – – –
1
2

LSBPW Hedge Fund Activity: Q2 2023 in Review

31 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q2 2023, worth a combined $304K — down 90% from $3.07M a quarter earlier.

Fund positioning in LSBPW was balanced in Q2 2023: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Cowen and Company, opening a new position worth an estimated $17K. The largest seller was Segantii Capital Management, exiting entirely with an estimated $320K sold.

  • 31 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $304K of LakeShore Biopharma Warrants stock for Q2 2023, down 90% quarter-over-quarter.
  • 2 funds opened new LakeShore Biopharma Warrants positions in Q2 2023 and 2 closed out, a net change of 0 holders.
  • The largest LakeShore Biopharma Warrants buyer in Q2 2023 was Cowen and Company, an estimated $17K added.
  • The largest LakeShore Biopharma Warrants seller in Q2 2023 was Segantii Capital Management, an estimated $320K sold.

Based on aggregated 13F filings for Q2 2023.